ChemicalBook--->CAS DataBase List--->2338-37-6

2338-37-6

2338-37-6 Structure

2338-37-6 Structure
IdentificationBack Directory
[Name]

levopropoxyphene
[CAS]

2338-37-6
[Synonyms]

HSDB 3414
l-Propoxyphene
Levopropossifene
levopropoxyphene
Levopropoxyphenum
levopropoxyphene USP/EP/BP
(1R,2S)-1-benzyl-3-dimethylamino-2-methyl-1-phenylpropyl propionate
(1R,2S)-3-(Dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)propyl propanoate
Benzeneethanol, α-[(1S)-2-(dimethylamino)-1-methylethyl]-α-phenyl-, 1-propanoate, (αR)-
[Molecular Formula]

C22H29NO2
[MDL Number]

MFCD00866848
[MOL File]

2338-37-6.mol
[Molecular Weight]

339.471
Chemical PropertiesBack Directory
[Melting point ]

75-76°
[alpha ]

D25 -68.2° (c = 0.6 in chloroform)
[Boiling point ]

444.0±45.0 °C(Predicted)
[density ]

1.038±0.06 g/cm3(Predicted)
[pka]

9.19±0.28(Predicted)
Safety DataBack Directory
[Hazardous Substances Data]

2338-37-6(Hazardous Substances Data)
Hazard InformationBack Directory
[Uses]

Antitussive.
[Definition]

ChEBI: Levopropoxyphene is a 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate. It has a role as an antitussive. It is an enantiomer of a dextropropoxyphene.
[Brand name]

Novrad(Lilly).
[Biological Functions]

Levopropoxyphene is the L-isomer of the analgesic agonist dextropropoxyphene. Levopropoxyphene is only mildly antitussive and is rarely used. It has no CNS effects. Side effects include dizziness and nausea. It is available as the napsylate derivative (Novrad) and is taken orally in the form of a liquid or less frequently as a capsule.
Tags:2338-37-6 Related Product Information
6700-34-1 77-23-6 151-05-3